Clinical Trial Diversity ‘Fundamental’ to FDA Mission, CDER Official Says
September 30, 2022
The need to increase clinical trial diversity was a much-discussed topic at the annual meeting of the Regulatory Affairs Professionals Society (RAPS) last month in Phoenix, with FDA and industry representatives weighing in.